[Mortality in treated XXXX ].

@entity1 @entity64 @entity101 @entity387 @entity301 @entity27 @entity1576 @entity65 @entity1030 @entity204 @entity25
Obstructive @entity387 is common and considered to be a risk factor for @entity101 , @entity64 and @entity301 . Accordingly, the presence of @entity387 is probably a predictor of @entity204 . Continuous positive airway pressure is an effective treatment of @entity27 . It has been demonstrated that such treatment improves @entity25 and quality-of-life. To determine mortality in @entity27 @entity1 treated with nasal continuous positive airway pressure, we followed 296 @entity1 given continuous positive airway pressure for 11 years 6 months. At the end of the study 26 of the 296 @entity1 had died, mainly from @entity65 . Mortality was 7% (95% confidence interval: 3%-9%) at 5 years. Three independent factors of @entity204 identified by forward stepwise selection were included in a Cox analysis. These factors were 1) smoking as a categorical covariate (>30 pack-years), 2) age and 3) forced expiratory volume in 1 s. When the 52 @entity1 with an associated @entity1030 (forced expiratory volume in 1 s/vital capacity<0.65) with @entity27 were excluded form analysis, mortality of the 244 remailing @entity1 was 2% at 5 years, a rate observed in the general population. Subsequently, it appears that nasal continuous positive airway pressure corrects for the risk of @entity204 suspected in @entity27 @entity1 . @entity27 @entity1 treated with continuous positive airway pressure is near to that of the general population, particularly when @entity1 with an associated chronic @entity1576 are excluded.
